In a letter to the Biden Administration, the organization conveyed recommendations to help ensure that eligible individuals can efficiently and effectively access additional COVID-19 doses at their local pharmacies.
AAM noted that its members have worked hard to enhance patient access to affordable treatments, such as manufacturing dexamethasone, throughout the pandemic.
Jeffrey K. France, vice president and general counsel at the Association for Accessible Medicines, discusses how two major decisions made by the Supreme Court implicates the biopharmaceutical competition.
The Consumer Health Products Association is sharing the speaker lineup for its 2021 Regulatory, Scientific and Quality Conference, which will take place virtually from Sept. 9 to 10.
The organization said it is looking forward to working with the administration to increase the $313 billion in savings that generic drugs generated in 2019, as well as build on the success of biosimilars in recent years.
Maine, as of July 9, had fully vaccinated 62.3% of its total population, including 72.9% of people aged 18 years old and older, according to the Centers for Disease Control and Prevention.
Ronna Hauser will head the new department as senior vice president of policy and pharmacy affairs, building on her prior role as the organization’s vice president of policy and government affairs operations.
